• レポートコード:GIR-2104Z11084 • 出版社/出版日:GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、106ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥487,200 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥730,800 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、感染症ポイントオブケア(POCT)検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染症ポイントオブケア(POCT)検査の種類別市場規模(免疫学的検査、病原体核酸検査)、用途別市場規模(病院、診療所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・感染症ポイントオブケア(POCT)検査の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott、Roche、Siemens、Danaher、Becton, Dickinson、Johnson & Johnson、Instrumentation Laboratory、PTS Diagnostics、Quidel、Sekisui Diagnostics、Nova、EKF Diagnostics、AccuBioTech、Trinity Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:免疫学的検査、病原体核酸検査 ・用途別分析2016年-2026年:病院、診療所、その他 ・感染症ポイントオブケア(POCT)検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・感染症ポイントオブケア(POCT)検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・感染症ポイントオブケア(POCT)検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・感染症ポイントオブケア(POCT)検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・感染症ポイントオブケア(POCT)検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Point of Care Testing for Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Point of Care Testing for Infectious Disease size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Point of Care Testing for Infectious Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Point of Care Testing for Infectious Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunological Test
Pathogen Nucleic Acid Test
Market segment by Application, can be divided into
Hospital
Clinics
Others
Market segment by players, this report covers
Abbott
Roche
Siemens
Danaher
Becton, Dickinson
Johnson & Johnson
Instrumentation Laboratory
PTS Diagnostics
Quidel
Sekisui Diagnostics
Nova
EKF Diagnostics
AccuBioTech
Trinity Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Point of Care Testing for Infectious Disease
1.2 Classification of Point of Care Testing for Infectious Disease by Type
1.2.1 Overview: Global Point of Care Testing for Infectious Disease Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Type in 2020
1.2.3 Immunological Test
1.2.4 Pathogen Nucleic Acid Test
1.3 Global Point of Care Testing for Infectious Disease Market by Application
1.3.1 Overview: Global Point of Care Testing for Infectious Disease Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Point of Care Testing for Infectious Disease Market Size & Forecast
1.5 Global Point of Care Testing for Infectious Disease Market Size and Forecast by Region
1.5.1 Global Point of Care Testing for Infectious Disease Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Point of Care Testing for Infectious Disease Market Size by Region, (2016-2021)
1.5.3 North America Point of Care Testing for Infectious Disease Market Size and Prospect (2016-2026)
1.5.4 Europe Point of Care Testing for Infectious Disease Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Point of Care Testing for Infectious Disease Market Size and Prospect (2016-2026)
1.5.6 South America Point of Care Testing for Infectious Disease Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Point of Care Testing for Infectious Disease Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Point of Care Testing for Infectious Disease Market Drivers
1.6.2 Point of Care Testing for Infectious Disease Market Restraints
1.6.3 Point of Care Testing for Infectious Disease Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point of Care Testing for Infectious Disease Product and Solutions
2.1.4 Abbott Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Point of Care Testing for Infectious Disease Product and Solutions
2.2.4 Roche Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Siemens
2.3.1 Siemens Details
2.3.2 Siemens Major Business
2.3.3 Siemens Point of Care Testing for Infectious Disease Product and Solutions
2.3.4 Siemens Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Siemens Recent Developments and Future Plans
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Point of Care Testing for Infectious Disease Product and Solutions
2.4.4 Danaher Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Danaher Recent Developments and Future Plans
2.5 Becton, Dickinson
2.5.1 Becton, Dickinson Details
2.5.2 Becton, Dickinson Major Business
2.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Product and Solutions
2.5.4 Becton, Dickinson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Becton, Dickinson Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Product and Solutions
2.6.4 Johnson & Johnson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Instrumentation Laboratory
2.7.1 Instrumentation Laboratory Details
2.7.2 Instrumentation Laboratory Major Business
2.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Product and Solutions
2.7.4 Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Instrumentation Laboratory Recent Developments and Future Plans
2.8 PTS Diagnostics
2.8.1 PTS Diagnostics Details
2.8.2 PTS Diagnostics Major Business
2.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
2.8.4 PTS Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 PTS Diagnostics Recent Developments and Future Plans
2.9 Quidel
2.9.1 Quidel Details
2.9.2 Quidel Major Business
2.9.3 Quidel Point of Care Testing for Infectious Disease Product and Solutions
2.9.4 Quidel Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Quidel Recent Developments and Future Plans
2.10 Sekisui Diagnostics
2.10.1 Sekisui Diagnostics Details
2.10.2 Sekisui Diagnostics Major Business
2.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
2.10.4 Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
2.11 Nova
2.11.1 Nova Details
2.11.2 Nova Major Business
2.11.3 Nova Point of Care Testing for Infectious Disease Product and Solutions
2.11.4 Nova Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Nova Recent Developments and Future Plans
2.12 EKF Diagnostics
2.12.1 EKF Diagnostics Details
2.12.2 EKF Diagnostics Major Business
2.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
2.12.4 EKF Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 EKF Diagnostics Recent Developments and Future Plans
2.13 AccuBioTech
2.13.1 AccuBioTech Details
2.13.2 AccuBioTech Major Business
2.13.3 AccuBioTech Point of Care Testing for Infectious Disease Product and Solutions
2.13.4 AccuBioTech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 AccuBioTech Recent Developments and Future Plans
2.14 Trinity Biotech
2.14.1 Trinity Biotech Details
2.14.2 Trinity Biotech Major Business
2.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Product and Solutions
2.14.4 Trinity Biotech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Trinity Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point of Care Testing for Infectious Disease Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Point of Care Testing for Infectious Disease Players Market Share
3.2.2 Top 10 Point of Care Testing for Infectious Disease Players Market Share
3.2.3 Market Competition Trend
3.3 Point of Care Testing for Infectious Disease Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Point of Care Testing for Infectious Disease Revenue and Market Share by Type (2016-2021)
4.2 Global Point of Care Testing for Infectious Disease Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2016-2021)
5.2 Point of Care Testing for Infectious Disease Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Point of Care Testing for Infectious Disease Revenue by Type (2016-2026)
6.2 North America Point of Care Testing for Infectious Disease Revenue by Application (2016-2026)
6.3 North America Point of Care Testing for Infectious Disease Market Size by Country
6.3.1 North America Point of Care Testing for Infectious Disease Revenue by Country (2016-2026)
6.3.2 United States Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
6.3.3 Canada Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
6.3.4 Mexico Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Point of Care Testing for Infectious Disease Revenue by Type (2016-2026)
7.2 Europe Point of Care Testing for Infectious Disease Revenue by Application (2016-2026)
7.3 Europe Point of Care Testing for Infectious Disease Market Size by Country
7.3.1 Europe Point of Care Testing for Infectious Disease Revenue by Country (2016-2026)
7.3.2 Germany Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
7.3.3 France Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
7.3.5 Russia Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
7.3.6 Italy Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Type (2016-2026)
8.2 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Application (2016-2026)
8.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region
8.3.1 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Region (2016-2026)
8.3.2 China Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8.3.3 Japan Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8.3.4 South Korea Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8.3.5 India Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
8.3.7 Australia Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Point of Care Testing for Infectious Disease Revenue by Type (2016-2026)
9.2 South America Point of Care Testing for Infectious Disease Revenue by Application (2016-2026)
9.3 South America Point of Care Testing for Infectious Disease Market Size by Country
9.3.1 South America Point of Care Testing for Infectious Disease Revenue by Country (2016-2026)
9.3.2 Brazil Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
9.3.3 Argentina Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Type (2016-2026)
10.2 Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Application (2016-2026)
10.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country
10.3.1 Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Country (2016-2026)
10.3.2 Turkey Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
10.3.4 UAE Point of Care Testing for Infectious Disease Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Point of Care Testing for Infectious Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Point of Care Testing for Infectious Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Point of Care Testing for Infectious Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Region (2016-2021)
Table 5. Global Point of Care Testing for Infectious Disease Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Point of Care Testing for Infectious Disease Product and Solutions
Table 9. Abbott Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Point of Care Testing for Infectious Disease Product and Solutions
Table 13. Roche Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Siemens Corporate Information, Head Office, and Major Competitors
Table 15. Siemens Major Business
Table 16. Siemens Point of Care Testing for Infectious Disease Product and Solutions
Table 17. Siemens Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Danaher Corporate Information, Head Office, and Major Competitors
Table 19. Danaher Major Business
Table 20. Danaher Point of Care Testing for Infectious Disease Product and Solutions
Table 21. Danaher Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Becton, Dickinson Corporate Information, Head Office, and Major Competitors
Table 23. Becton, Dickinson Major Business
Table 24. Becton, Dickinson Point of Care Testing for Infectious Disease Product and Solutions
Table 25. Becton, Dickinson Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson & Johnson Major Business
Table 28. Johnson & Johnson Point of Care Testing for Infectious Disease Product and Solutions
Table 29. Johnson & Johnson Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Instrumentation Laboratory Corporate Information, Head Office, and Major Competitors
Table 31. Instrumentation Laboratory Major Business
Table 32. Instrumentation Laboratory Point of Care Testing for Infectious Disease Product and Solutions
Table 33. Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. PTS Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. PTS Diagnostics Major Business
Table 36. PTS Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
Table 37. PTS Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Quidel Corporate Information, Head Office, and Major Competitors
Table 39. Quidel Major Business
Table 40. Quidel Point of Care Testing for Infectious Disease Product and Solutions
Table 41. Quidel Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Sekisui Diagnostics Major Business
Table 44. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
Table 45. Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Nova Corporate Information, Head Office, and Major Competitors
Table 47. Nova Major Business
Table 48. Nova Point of Care Testing for Infectious Disease Product and Solutions
Table 49. Nova Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. EKF Diagnostics Corporate Information, Head Office, and Major Competitors
Table 51. EKF Diagnostics Major Business
Table 52. EKF Diagnostics Point of Care Testing for Infectious Disease Product and Solutions
Table 53. EKF Diagnostics Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. AccuBioTech Corporate Information, Head Office, and Major Competitors
Table 55. AccuBioTech Major Business
Table 56. AccuBioTech Point of Care Testing for Infectious Disease Product and Solutions
Table 57. AccuBioTech Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 59. Trinity Biotech Major Business
Table 60. Trinity Biotech Point of Care Testing for Infectious Disease Product and Solutions
Table 61. Trinity Biotech Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Players (2019-2021)
Table 63. Global Point of Care Testing for Infectious Disease Revenue Share by Players (2019-2021)
Table 64. Breakdown of Point of Care Testing for Infectious Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Point of Care Testing for Infectious Disease Players Head Office, Products and Services Provided
Table 66. Point of Care Testing for Infectious Disease Mergers & Acquisitions in the Past Five Years
Table 67. Point of Care Testing for Infectious Disease New Entrants and Expansion Plans
Table 68. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Type (2016-2021)
Table 69. Global Point of Care Testing for Infectious Disease Revenue Share by Type (2016-2021)
Table 70. Global Point of Care Testing for Infectious Disease Revenue Forecast by Type (2021-2026)
Table 71. Global Point of Care Testing for Infectious Disease Revenue by Application (2016-2021)
Table 72. Global Point of Care Testing for Infectious Disease Revenue Forecast by Application (2021-2026)
Table 73. North America Point of Care Testing for Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Point of Care Testing for Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Point of Care Testing for Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Point of Care Testing for Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Point of Care Testing for Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Point of Care Testing for Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Point of Care Testing for Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Point of Care Testing for Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Point of Care Testing for Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Point of Care Testing for Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Point of Care Testing for Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Point of Care Testing for Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Point of Care Testing for Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Point of Care Testing for Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Point of Care Testing for Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Point of Care Testing for Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Point of Care Testing for Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Point of Care Testing for Infectious Disease Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Point of Care Testing for Infectious Disease Picture
Figure 2. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type in 2020
Figure 3. Immunological Test
Figure 4. Pathogen Nucleic Acid Test
Figure 5. Point of Care Testing for Infectious Disease Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Point of Care Testing for Infectious Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Point of Care Testing for Infectious Disease Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Point of Care Testing for Infectious Disease Revenue Market Share by Region (2016-2026)
Figure 12. Global Point of Care Testing for Infectious Disease Revenue Market Share by Region in 2020
Figure 13. North America Point of Care Testing for Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Point of Care Testing for Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Point of Care Testing for Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Point of Care Testing for Infectious Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Point of Care Testing for Infectious Disease Market Drivers
Figure 18. Point of Care Testing for Infectious Disease Market Restraints
Figure 19. Point of Care Testing for Infectious Disease Market Trends
Figure 20. Abbott Recent Developments and Future Plans
Figure 21. Roche Recent Developments and Future Plans
Figure 22. Siemens Recent Developments and Future Plans
Figure 23. Danaher Recent Developments and Future Plans
Figure 24. Becton, Dickinson Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Instrumentation Laboratory Recent Developments and Future Plans
Figure 27. PTS Diagnostics Recent Developments and Future Plans
Figure 28. Quidel Recent Developments and Future Plans
Figure 29. Sekisui Diagnostics Recent Developments and Future Plans
Figure 30. Nova Recent Developments and Future Plans
Figure 31. EKF Diagnostics Recent Developments and Future Plans
Figure 32. AccuBioTech Recent Developments and Future Plans
Figure 33. Trinity Biotech Recent Developments and Future Plans
Figure 35. Global Point of Care Testing for Infectious Disease Revenue Share by Players in 2020
Figure 36. Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Point of Care Testing for Infectious Disease Revenue Market Share in 2020
Figure 38. Global Top 10 Players Point of Care Testing for Infectious Disease Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Point of Care Testing for Infectious Disease Revenue Share by Type in 2020
Figure 41. Global Point of Care Testing for Infectious Disease Market Share Forecast by Type (2021-2026)
Figure 42. Global Point of Care Testing for Infectious Disease Revenue Share by Application in 2020
Figure 43. Global Point of Care Testing for Infectious Disease Market Share Forecast by Application (2021-2026)
Figure 44. North America Point of Care Testing for Infectious Disease Sales Market Share by Type (2016-2026)
Figure 45. North America Point of Care Testing for Infectious Disease Sales Market Share by Application (2016-2026)
Figure 46. North America Point of Care Testing for Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 47. United States Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Point of Care Testing for Infectious Disease Sales Market Share by Type (2016-2026)
Figure 51. Europe Point of Care Testing for Infectious Disease Sales Market Share by Application (2016-2026)
Figure 52. Europe Point of Care Testing for Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 53. Germany Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Point of Care Testing for Infectious Disease Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Point of Care Testing for Infectious Disease Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Share by Region (2016-2026)
Figure 61. China Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Point of Care Testing for Infectious Disease Sales Market Share by Type (2016-2026)
Figure 68. South America Point of Care Testing for Infectious Disease Sales Market Share by Application (2016-2026)
Figure 69. South America Point of Care Testing for Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Point of Care Testing for Infectious Disease Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Point of Care Testing for Infectious Disease Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Point of Care Testing for Infectious Disease Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Point of Care Testing for Infectious Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source